Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramesh Narayanan

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2024
A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticitySarah Asemota, Wendy Effah, Jeremiah Holt, et al.
Cell Reports|June 23, 2021
Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancerAjeeth K Pingili, Mehdi Chaib, Laura M Sipe, et al.
Iscience|November 8, 2019
Androgen Receptor Is a Non-canonical Inhibitor of Wild-Type and Mutant Estrogen Receptors in Hormone Receptor-Positive Breast CancersSuriyan Ponnusamy, Sarah Asemota, Lee S Schwartzberg, et al.
Cell Reports|November 18, 2023
Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtypeSarah Asemota, Wendy Effah, Kirsten L Young, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2024
A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticitySarah Asemota, Wendy Effah, Jeremiah Holt, et al.
Cell Reports|June 23, 2021
Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancerAjeeth K Pingili, Mehdi Chaib, Laura M Sipe, et al.
Iscience|November 8, 2019
Androgen Receptor Is a Non-canonical Inhibitor of Wild-Type and Mutant Estrogen Receptors in Hormone Receptor-Positive Breast CancersSuriyan Ponnusamy, Sarah Asemota, Lee S Schwartzberg, et al.
Cell Reports|November 18, 2023
Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtypeSarah Asemota, Wendy Effah, Kirsten L Young, et al.
Pageof 8